Nahia Gómez-Echarte

6PUBLICATIONS
29CO-AUTHORS
Haematological tumoursMolecular targetsMajor global burdens of diseaseMedical devicesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Multiple myeloma: A tale of deregulated transcription factors.

|Jun 05, 2026
IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

|Jul 02, 2024
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal

|Mar 28, 2024
Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice.

Sheila Maestro, Nahia Gomez-Echarte, Gracian Camps

|Apr 30, 2021
AAV-HDV: An Attractive Platform for the In Vivo Study of HDV Biology and the Mechanism of Disease Pathogenesis.

Sheila Maestro, Nahia Gómez-Echarte, Gracián Camps

|Apr 30, 2021
The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma.

Arantxa Carrasco-León, Ane Amundarain, Nahia Gómez-Echarte

Pageof 1

Frequent Collaborators

4 joint publications

Felipe Prósper

4 joint publications

Xabier Agirre

3 joint publications

Edurne San-José Enériz

2 joint publications

Paula Rodriguez-Otero